Viewing nowCombinationEmpamax S Tablet 10/100 Milligrams (Empagliflozin, Sitagliptin)
Sitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 12.55mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202500822 · Approved 2025.04.07 · Insurance code 643309800
Improvement of blood sugar control in type 2 diabetes
This medication is used as an adjunct to dietary and exercise therapy to assist in blood sugar control in adults with type 2 diabetes, combining the use of Empagliflozin and Sitagliptin.
The recommended starting dose of this medication is 1 time daily with Empagliflozin 10 mg/Sitagliptin 100 mg. If well tolerated and additional blood sugar control is needed, the dose can be increased to 1 time daily with Empagliflozin 25 mg/Sitagliptin 100 mg. This medication can be taken without regard to meals and should be swallowed whole. If a dose is missed, take it as soon as remembered, but do not take double the dose on the same day.
This medication may cause allergic reactions. If severe rash, swelling, or difficulty breathing occurs, discontinue use immediately and consult a doctor. This medication can cause serious pancreatic inflammation known as acute pancreatitis; if abdominal pain, vomiting, or loss of appetite occurs during use, seek medical attention immediately. This medication should not be used in certain patients, such as those who have had allergic reactions or have type 1 diabetes or diabetic ketoacidosis. Patients with renal impairment should have their kidney function monitored regularly while using this medication, and it is recommended not to use it if kidney function is severely impaired. During use, symptoms of hypoglycemia may occur, particularly if taking insulin or other antidiabetic agents, so blood sugar should be checked frequently, and symptoms should be monitored. This medication may increase the risk of genital infections or urinary tract infections; if symptoms of infection occur, consult medical personnel immediately. Elderly patients or those at risk of reduced fluid volume should be cautious of dehydration or hypotension, and may need to temporarily discontinue medication if necessary. Its safety during pregnancy or breastfeeding has not been established, so it is not recommended during these periods. While taking this medication, it is important to have regular blood tests, kidney function tests, and eye exams to monitor health status. Take care when driving or operating machinery as there is a risk of accidents due to hypoglycemia. In case of overdose, seek medical attention immediately for appropriate treatment, and it is unclear if dialysis can remove this medication. This medication should be kept out of reach of children and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to avoid exposure to air or moisture, and it is best to keep it at room temperature between 1 and 30 degrees Celsius. This storage method will help maintain the effectiveness and safety of the medication.
Pale pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 12.55mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 31.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.